CVB FINANCIAL CORP. (CVBF): what the price assumes

In the published model solve dated 2026-Q2, anchored at $22.19, CVB FINANCIAL CORP. (CVBF) is priced for 10.5% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-08-31 · Source: https://boothcheck.com/report/CVBF

Headline

FieldValue
TickerCVBF
CompanyCVB FINANCIAL CORP.
Sector / IndustryFinancial Services
Current price$22.19/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed10.5%
Return on equity now9.1%
ROE gap+1.4pp
Price-to-book1.23x

Solve inputs: computed at a 9.2% cost of equity with 4% terminal growth over a 10-year stage, on common book equity (FY2026).

How unusual the bet is: within-range

ReferenceValue
vs own history+0.28σ
cohort percentile (of 122 peers)39
sustained it ~10 years at this level75%
implied end-window share0%

Valuation X-Ray

Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.75x3expensive
Earnings1.41x1expensive
Relative0
Growth1.61x2expensive

Families that call it expensive: Asset, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 5.2%); the inversion above states its own rate.

Per-Model Detail (n=6)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthno
Bank Fair Value (P/TBV)$5.554.00xyesTBVPS $11.09 × 0.50x (ROE (TTM) 6.5% / CoE 9.3%, g=4.2% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption))
Relative ValuationRelativenoP/E 12.66x (blended: static sector reference 10x + trailing (TTM) 19x), scenarios: 10.4x / 12.7x / 15.0x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDMGrowth$24.300.91xyesDPS $0.62, g=6.5% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$9.642.30xyesStage 1: 0% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$12.711.75xyesBV/sh $18.01, ROE (TTM) 6.5%, ke 9.3%
Two-Stage Excess ReturnAsset$10.522.11xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowthnoRev $0.5B, growth 16% (input: historical growth; tapered), Terminal P/S: 6.2x / 7.5x / 8.9x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelativenoEPS $1.46, growth 0% (input: historical EPS growth), PEG=143.70 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAssetno
Graham NumberAsset$24.320.91xyes√(22.5 × EPS $1.46 × BVPS $18.01) — Graham's conservative floor
EV/EBITDA RelativeRelativeno
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsnoEPS $1.46 × (8.5 + 2×0.1%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelativeno
PEG Fair ValueRelativenoEPS $1.46 × (PEG 1.5 × growth 0.1% (input: historical EPS growth)) → PE 0.2x
Earnings YieldEarnings$15.781.41xyesEPS $1.46 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

The issuer is a funded financial business. Debt, interest, and cash flows are operating inputs, so industrial EV, net-debt, WACC, and free-cash-flow lenses do not apply; value the common-equity claim with book, earnings, capital, and payout economics.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Community Banking (whole company)financialequity0.5B reported-currencywithheldunresolved standalone equity facts required

No unit-level total common-equity value is stated. Each financial unit requires supported standalone common equity, normalized earnings, capital adequacy, and payout capacity. Consolidated debt, interest, and cash are operating balances, not an enterprise-to-equity bridge; company-level book, earnings, capital, and payout lenses remain the coherent cross-checks.

Solvency

FieldValue
Share count CAGR (dilution)4.5%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

Every standard way of valuing a bank puts CVB Financial below where it trades, and buyers have paid the premium anyway. The reason is not on the lending side. It is in how the money arrives. Average noninterest-bearing deposits were 58.98% of total deposits during 2025, and the annual filing explains where they come from: "The largest percentage of our deposits, 43%, are non-analyzed business accounts, which represent customer operating accounts that generally utilize a wide array of treasury management products." Those are the checking accounts businesses run payroll out of. They pay nothing, they move slowly, and they are attached to a relationship rather than to a rate.

Cheap funding changes the arithmetic of an ordinary loan book. Cost of funds fell 29 basis points during 2025, and net interest income reached $460.3 million, up 2.89% on the year, even though interest income itself fell by $36.8 million. Read that sequence twice. The bank earned more from lending while its assets yielded less, because what it pays for money fell faster than what it collects. The expense base does the rest: "The efficiency ratio was 46.03% for 2025, compared to 46.55% for 2024 and 42.00% for 2023." Under half of net revenue goes to running the bank, which is what turns a modest asset yield into a genuinely profitable institution.

Credit has been improving rather than deteriorating, which is not the direction most commercial loan books have been travelling. Nonaccrual loans stood at $4.7 million as of December 31, 2025, against $27.8 million a year earlier. A nonaccrual loan is one the bank has stopped booking interest on because it no longer expects to collect, so a drop of that size is not an accounting adjustment. It is borrowers paying.

The return picture is also better than the headline number suggests, and the reason matters. The filing reports that "Net earnings of $209.3 million produced a return on average equity (ROAE) of 9.26%, a return on average tangible common equity (ROATCE) of 14.28%". The gap between those two figures is goodwill from past acquisitions, which sits inside book equity but does not lend to anyone. Measured on the capital that actually works, the bank earns in the mid-teens, and that is the figure the premium multiple is tracking.

Management hands most of the profit back. About 91.8% of earnings went out as dividends and repurchases in the latest fiscal year, which for a bank with no need to fund rapid balance-sheet growth is the honest use of the money. The fair objection is that a premium multiple leaves no room for a weak quarter, and the second quarter of 2026 was one. That is a question about the price rather than about the deposit franchise underneath it.

Bear Case

Two things are priced into this bank, and only one of them is about lending. The first is that the deposit mix holds. The second is that returns climb from here to a level few banks reach and fewer keep. The fragile one is the first, and it is already drifting: average noninterest-bearing deposits were 58.98% of total deposits during 2025, against 59.92% during 2024. That reads like rounding. It is not. That mix is the margin, and every point of it that migrates from a free checking account into a money-market balance gets paid for out of net interest income.

The second assumption does not survive contact with arithmetic. The shares change hands near 1.7 times book. Backing out what that requires produces no number at all, because the return needed sits above what even a forty-year run at the elite tier of bank returns would justify. The bank has recently been earning about 9.1%, and the return shareholders are assumed to demand for the risk is about 9.3%. A bank earning roughly what its owners require is, in the textbook version, worth about its book value. This one carries nearly twice that, and its price-to-book sits at the very top of its peer group. Of the firms that have reached the kind of return the price needs, only about two thirds were still earning it a decade later.

The capital-return policy closes the other escape route. Roughly 91.8% of earnings left the company as dividends and repurchases in the latest fiscal year, leaving under a tenth of profit retained inside the bank. Retained profit is how book value compounds. With almost none held back, the premium cannot be grown into. It has to be earned by producing a higher return on the equity already there, in a business where that return is set by deposit costs and loan demand rather than by anyone's preference.

The loan book carries its own quiet exposure. Alongside commercial real estate and commercial and industrial lending, the bank runs a dairy, livestock and agribusiness portfolio, and the filing is candid about what that collateral is worth when things go wrong: "the limited purpose of some agricultural-related collateral affects credit risk because such collateral may have limited or no other uses to support values when loan repayment problems emerge". The deposit base has been drifting as well. Total deposits were $11.95 billion at March 31, 2026, down $126.8 million, or 1.05%, from $12.07 billion at December 31, 2025.

Then the print. Second-quarter 2026 earnings came to $0.29 a share against a Q2 2026 consensus of $0.41, on revenue of $179.4 million against $195.6 million expected. One quarter proves nothing about a franchise. It proves a good deal about a multiple, because a bank carrying nearly twice its book value has already spent the benefit of the doubt.

Valuation

The multiple is where this one starts. CVB Financial changes hands near 1.7 times its book value, and inverting that does not produce a clean answer: the return on equity the price requires sits above what even four decades at the elite tier of bank returns would support. The arithmetic runs out before it resolves, and that non-answer is itself the finding. For context, the bank has recently earned about 9.1% on its equity, while the return shareholders are assumed to require is about 9.3%.

The methods line up on one side. The earnings-power lens comes closest and still leaves the price about 9% above it. Beyond that, the price sits roughly 34% above the asset-value methods, about 38% above peer multiples, and about 39% above the forward-growth methods. When the closest method is the one that simply capitalises current profit, and every richer frame lands lower, the premium is not being paid for growth. It is being paid for quality of earnings, which is a real thing and also an unfalsifiable one until a downturn tests it.

Against its own cohort the position is unambiguous, with this price-to-book sitting at the very top of the community-bank peer group. The filed inputs behind that position are the ones already described, an efficiency ratio of 46.03% for 2025 and average noninterest-bearing deposits at 58.98% of the total. Both are genuinely stronger than an ordinary community lender manages. Whether they are worth the distance between this multiple and the rest of the cohort is the open question.

Deposits and float fund a bank, so the usual leverage and coverage arithmetic does not describe one; the frame is regulatory capital and how much of the earnings can be handed back. Here that was about 91.8% in the latest fiscal year, through dividends and repurchases. A bank returning nine tenths of its profit is saying it does not need capital to grow, which is a compliment to the business and a constraint on the equity story: book value compounds slowly when almost nothing is retained, so the multiple has to be defended by the return itself, quarter after quarter.

Catalysts

The second quarter of 2026, reported on July 22, 2026, was a miss of some size. Net earnings came to $48.3 million, or $0.29 a share, against a Q2 2026 consensus of $0.41, with revenue of $179.4 million against a $195.6 million consensus. For a bank valued near twice its book, the composition of that shortfall matters more than the size of it: a provision build reverses, a funding-cost squeeze does not.

The deposit line is where to look for the answer. The first-quarter filing shows total deposits of $11.95 billion at March 31, 2026, down $126.8 million, or 1.05%, from $12.07 billion at December 31, 2025, with noninterest-bearing balances at 59.44% of total deposits at the end of that quarter. Those two facts pull in opposite directions, a slightly smaller pool of deposits but a slightly richer mix inside it, and the next disclosure resolves which one is the trend.

The company also announced the appointment of a new director on July 22, 2026, alongside the results. Board changes are rarely the story on their own, but for a mature bank whose capital policy sends nearly all of its earnings out the door, who sits on the board is one of the few levers that can change where that capital goes.

Peer Cohorts (Per Segment, With Filing Citations)

Community Banking (whole company) (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q2 2026 earnings release, July 22, 2026 · Q1 FY2026 10-Q · company announcement, July 22, 2026

View the full interactive CVBF report on boothcheck